Skip to main content

Briumvi Side Effects

Generic name: ublituximab

Medically reviewed by Drugs.com. Last updated on Jul 13, 2024.

Note: This document provides detailed information about Briumvi Side Effects associated with ublituximab. Some dosage forms listed on this page may not apply specifically to the brand name Briumvi.

Applies to ublituximab: intravenous solution.

Serious side effects of Briumvi

Along with its needed effects, ublituximab (the active ingredient contained in Briumvi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ublituximab:

More common side effects

  • body aches or pain
  • chest pain or tightness
  • chills
  • cough
  • cough producing mucus
  • diarrhea
  • dizziness
  • dryness or soreness of the throat
  • ear congestion
  • facial swelling
  • fever or chills
  • general feeling of discomfort or illness
  • headache
  • hoarseness
  • joint pain
  • loss of voice
  • muscle aches and pains
  • nausea or vomiting
  • pain or tenderness around the eyes and cheekbones
  • skin rash
  • sneezing
  • stuffy or runny nose
  • sweating
  • tender, swollen glands in the neck
  • trouble breathing
  • trouble in swallowing
  • trouble sleeping
  • unusual tiredness or weakness
  • voice changes
  • vomiting

Incidence not known

  • back pain
  • blurred vision
  • confusion
  • dark urine
  • drowsiness
  • light-colored stools
  • seizures
  • upper right abdominal or stomach pain
  • yellow eyes and skin

Other side effects of Briumvi

Some side effects of ublituximab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

  • pain in the arms or legs

Managing side effects (general information)

For healthcare professionals

Applies to ublituximab: intravenous solution.

General adverse events

The most common adverse reactions, with a frequency of 10% or greater, were infusion reactions and upper respiratory tract infections. The most common cause that led to treatment discontinuation was infection.

Immunologic

Musculoskeletal

Other

The most reported infusion reaction symptoms, with a frequency of 5% or greater, include pyrexia, chills, headache, and influenza-like illness.

Serious infusion reactions occurred in 0.6% of patients.[Ref]

Psychiatric

Respiratory

Upper respiratory tract infections include nasopharyngitis, upper respiratory tract infection, respiratory tract infection (viral), pharyngitis, rhinitis, sinusitis, acute sinusitis, tonsillitis, laryngitis, chronic sinusitis, viral pharyngitis, viral rhinitis, viral upper respiratory tract infection, chronic tonsillitis, pharyngitis streptococcal, bacterial sinusitis, and bacterial tonsillitis.

Lower respiratory tract infections include bronchitis, pneumonia, tracheitis, tracheobronchitis, COVID-19 pneumonia, bacterial bronchitis, and viral pneumonia.[Ref]

References

1. (2022) "Product Information. Briumvi (ublituximab)." TG Therapeutics, Inc.

Frequently asked questions

Further information

Briumvi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer